Percutaneous Image-Guided Cryoablation as Second-Line Therapy of Soft-Tissue Venous Vascular Malformations of Extremities: A Prospective Study of Safety and 6-Month Efficacy

2017 ◽  
Vol 40 (9) ◽  
pp. 1358-1366 ◽  
Author(s):  
F. H. Cornelis ◽  
C. Labrèze ◽  
V. Pinsolle ◽  
Y. Le Bras ◽  
C. Castermans ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Prospective Study ◽  
Vascular Malformations ◽  
Second Line ◽  
Second Line Therapy ◽  
Image Guided ◽  
Line Therapy ◽  
A Prospective Study

scholarly journals A prospective study of S-1 + Irinotecan plus bevacizumab as second-line therapy in metastatic colorectal cancer (KSCC1102)

2015 ◽  
Vol 26 ◽  
pp. vii100
Author(s):  
Hiroaki Tanioka ◽  
Akihito Tsuji ◽  
Yasunori Emi ◽  
Shimokawa Mototsugu ◽  
Yuji Miyamoto ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Prospective Study ◽  
Metastatic Colorectal Cancer ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
A Prospective Study

Lack of Response to Imatinib Mesylate as Second-Line Therapy in a Patient with C-Kit Positive Metastatic Soft Tissue Leiomyosarcoma

2005 ◽  
Vol 91 (1) ◽  
pp. 103-103 ◽  
Author(s):  
Nicola Silvestris ◽  
Hector Soto Parra ◽  
Francesco Angelini ◽  
Serena Di Cosimo ◽  
Modesto D'Aprile ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Imatinib Mesylate ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy

scholarly journals Efficacy and Toxicity of Gemcitabine Plus Docetaxel Combination as a Second Line Therapy for Patients with Advanced Stage Soft Tissue Sarcoma

2012 ◽  
Vol 13 (2) ◽  
pp. 463-467 ◽  
Author(s):  
Kaya Ali Osman ◽  
Buyukberber Suleyman ◽  
Ozkan Metin ◽  
Alkis Necati ◽  
Sevinc Alper ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Advanced Stage ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy

Second line therapy in rheumatoid arthritis — A four year prospective study

1985 ◽  
Vol 4 (2) ◽  
pp. 133-142 ◽  
Author(s):  
T. Pullar ◽  
J. A. Hunter ◽  
H. A. Capell
Keyword(s):  
Rheumatoid Arthritis ◽  
Prospective Study ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy

scholarly journals Patient reported side-effects of prednisone and methotrexate in a real-world sarcoidosis population

2021 ◽  
Vol 18 ◽  
pp. 147997312110319
Author(s):  
Vivienne Kahlmann ◽  
Catharina C Moor ◽  
Marcel Veltkamp ◽  
Marlies S Wijsenbeek
Keyword(s):  
Side Effects ◽  
Prospective Study ◽  
Medication Use ◽  
Pulmonary Sarcoidosis ◽  
First Line ◽  
Second Line Therapy ◽  
Information Meeting ◽  
Line Therapy ◽  
Patient Reported ◽  
A Prospective Study

Currently prednisone is the first-line pharmacological treatment option for pulmonary sarcoidosis. Methotrexate is used as second-line therapy and seems to have fewer side-effects. No prospective comparative studies of first-line treatment with methotrexate exist. In this study, we evaluated patient reported presence and bothersomeness of side-effects of prednisone and methotrexate in a sarcoidosis population to guide the design of a larger prospective study. During a yearly patient information meeting 67 patients completed a questionnaire on medication use; 11 patients never used prednisone or methotrexate and were excluded from further analysis. Of the remaining 56 patients, 89% used prednisone and 70% methotrexate (present or former). Significantly more side-effects were reported for prednisone than for methotrexate, 78% versus 49% ( p = 0.006). In conclusion, methotrexate seems to have fewer and less bothersome side-effects than prednisone. These findings need to be confirmed in a prospective study.

Sign in / Sign up

Export Citation Format

Share Document